StockNews.AI
PM
StockNews.AI
201 days

Philip Morris International to Host Webcast of 2024 Fourth-Quarter and Full-Year Results

1. PMI to host Q4 2024 earnings webcast on February 6, 2025. 2. Investment in smoke-free products exceeds $12.5 billion since 2008. 3. Smoke-free products represent 38% of total 2024 revenues so far. 4. FDA has authorized IQOS as a Modified Risk Tobacco Product. 5. PMI aims to expand into wellness and healthcare markets.

Earnings
+0.05%Current Return
VS
-0.26%S&P 500
$130.140101/30 01:00 PM EDTEvent Start
$130.201/31 07:28 PM EDTLatest Updated
4m saved
Insight
Article

FAQ

Why Bullish?

Strong investment in smoke-free products supports future revenue growth, similar to past success with ZYN.

How important is it?

Earnings call could drive investor interest and affect stock value, especially with smoke-free focus.

Why Long Term?

PMI's long-term strategy in smoke-free and wellness markets suggests sustained price influence.

Related Companies

SWMAFPM
STAMFORD, CT--(BUSINESS WIRE)--Regulatory News: Philip Morris International Inc. (PMI) (NYSE: PM) will host a live audio webcast at www.pmi.com/2024Q4earnings on Thursday, February 6, 2025, at 9:00 a.m. ET, to discuss its 2024 Fourth-Quarter and Full-Year financial results, which will be issued at approximately 7:00 a.m. ET the same day. The webcast will be hosted by Jacek Olczak, Chief Executive Officer, and Emmanuel Babeau, Chief Financial Officer, and will include discussion of PMI’s financial results and a Q&A session with the investment community. The webcast will be in a listen-only mode. The webcast may also be accessed on mobile devices by downloading PMI’s Investor Relations App at www.pmi.com/irapp. The webcast recording and the slides and script will be available at www.pmi.com/2024Q4earnings. The recording will be available until 5:00 p.m. ET on Friday, March 7, 2025. Philip Morris International: Delivering a Smoke-Free Future Philip Morris International (PMI) is a leading international tobacco company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company’s current product portfolio primarily consists of cigarettes and smoke-free products. Since 2008, PMI has invested over $12.5 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. In 2022, PMI acquired Swedish Match – a leader in oral nicotine delivery – creating a global smoke-free champion led by the companies’ IQOS and ZYN brands. The U.S. Food and Drug Administration has authorized versions of PMI’s IQOS devices and consumables and Swedish Match’s General snus as Modified Risk Tobacco Products. Renewal applications for these IQOS products are pending before the FDA. As of June 30, 2024, PMI's smoke-free products were available for sale in 90 markets, and PMI estimates that 36.5 million adults around the world use PMI's smoke-free products. The smoke-free business accounted for approximately 38% of PMI’s total first-nine months 2024 net revenues. With a strong foundation and significant expertise in life sciences, PMI has a long-term ambition to expand into wellness and healthcare areas and aims to enhance life through the delivery of seamless health experiences. References to “PMI”, “we”, “our” and “us” mean Philip Morris International Inc., including its subsidiaries. For more information, please visit www.pmi.com and www.pmiscience.com.

Related News